Michael Roberts
Michael Roberts, Co-Founder and CEO at GenomeKey, leads the charge in enabling targeted sepsis treatment within hours rather than days. GenomeKey employs cutting-edge machine learning and DNA sequencing to drastically reduce the time it takes for doctors to determine the appropriate antibiotic for sepsis treatment. This innovation is crucial, as sepsis, a condition that can be fatal within hours, ...
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
Michael Roberts
Industry
N/A
Technology
N/A
Location
United States of America
Founded
N/A
Employees
N/A
Category
UDM
Contact Information
Email
mrrobert@wharton.upenn.edu
Phone
N/A
Address
N/A